Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - comprimés pelliculés - axitinibum 5 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.46 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 165.60 mg. - carcinome à cellules rénales - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - comprimés pelliculés - axitinibum 7 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.64 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 231.84 mg. - carcinome à cellules rénales - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - alectinibum - gélules - alectinibum 150 mg ut alectinibi hydrochloridum, lactosum monohydricum 33.67 mg, hydroxypropylcellulosum, natrii laurilsulfas corresp. natrium 6 mg, carmellosum calcicum, magnesii stearas, kapselhülle: carrageenanum, kalii chloridum, e 171, cera carnauba, maydis amylum, hypromellosum, drucktinte: e 172 (rubrum), e 172 (flavum), e 132, cera carnauba, lacca, polyglyceroli-3 mono-oleas, pro capsula. - non à petites cellules du poumon (nsclc) - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - comprimés pelliculés - axitinibum 1 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.21 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 33.60 mg. - carcinome à cellules rénales - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - comprimés pelliculés - axitinibum 5 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.37 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 58.8 mg. - carcinome à cellules rénales - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - comprimés pelliculés - axitinibum 3 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.22 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 35.30 mg. - carcinome à cellules rénales - synthetika

Thụy Sĩ - Tiếng Pháp - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - comprimés pelliculés - axitinibum 7 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.51 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 82.32 mg. - carcinome à cellules rénales - synthetika

Liên Minh Châu Âu - Tiếng Pháp - EMA (European Medicines Agency)

pfizer europe ma eeig  - axitinib - carcinome, cellule rénale - inhibiteurs de protéines kinases - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.

Canada - Tiếng Pháp - Health Canada

pfizer canada ulc - axitinib - comprimé - 3mg - axitinib 3mg - antineoplastic agents

Canada - Tiếng Pháp - Health Canada

pfizer canada ulc - axitinib - comprimé - 7mg - axitinib 7mg - antineoplastic agents